Clinical Trials
7 trialsNCT00255801 2018-08-16
Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00056056 2018-07-09
Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Terminated
NCT01504490 2017-02-14
Phase I Study of CS-7017 and Bexarotene
Georgetown University
Phase 1 Terminated
NCT00127101 2015-04-21
An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)
Merck Sharp & Dohme LLC
Phase 1 Terminated
NCT00660231 2014-12-03
GemBex
University College, London
Phase 2 Completed
NCT00030589 2013-12-18
Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00030849 2013-04-04
Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed